Recall: D-0437-2017

Class II - Potentially Harmful

Class IIClassification

2016-12-22Initiated

TerminatedStatus

Roxane Laboratories, Inc.Firm

Product

Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31.

Reason

Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.